Vyepti
Chemical Name | eptinezumab-jjmr |
Dosage Form | Injectable (intravenous; 100 mg/mL) |
Drug Class | Receptor antagonists |
System | Nervous |
Company | Lundbeck |
Approval Year | 2020 |
Indication
- Vyepti is indicated for the preventive treatment of migraine in adults.